Eventide Asset Management – REGENERON PHARMACEUTICALS INC

Eventide Asset Management ownership history of REGENERON PHARMACEUTICALS INC
QuarterValueSharesWeighting
Q4 2020$14,928
-13.7%
30,9000.0%0.23%
-32.4%
Q3 2020$17,297
-10.2%
30,9000.0%0.34%
-19.1%
Q2 2020$19,271
27.7%
30,9000.0%0.42%
-14.3%
Q1 2020$15,088
62.4%
30,900
34.3%
0.49%
43.4%
Q3 2018$9,293
17.1%
23,0000.0%0.34%
3.6%
Q2 2018$7,935
0.2%
23,0000.0%0.33%
-11.3%
Q1 2018$7,920
180.9%
23,000
206.7%
0.37%
152.4%
Q4 2017$2,820
-15.9%
7,5000.0%0.15%
-22.6%
Q3 2017$3,353
-9.0%
7,5000.0%0.19%
-17.0%
Q2 2017$3,6847,5000.23%